Pneumococcal conjugate 7-valent vaccine – consisting of 2-4 µg of capsular polysaccharide antigens from the following serotypes - 4, 6B, 9V, 14, 18C, 19F, 20, and 23F conjugated to non-toxic diphtheria toxin (CRM197).
Publisher' newest research report, the “7-Valent Pneumococcal Vaccine Industry Forecast” looks at past sales and reviews total world 7-Valent Pneumococcal Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected 7-Valent Pneumococcal Vaccine sales for 2023 through 2029. With 7-Valent Pneumococcal Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 7-Valent Pneumococcal Vaccine industry.
This Insight Report provides a comprehensive analysis of the global 7-Valent Pneumococcal Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 7-Valent Pneumococcal Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global 7-Valent Pneumococcal Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 7-Valent Pneumococcal Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 7-Valent Pneumococcal Vaccine.
The global 7-Valent Pneumococcal Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for 7-Valent Pneumococcal Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for 7-Valent Pneumococcal Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for 7-Valent Pneumococcal Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key 7-Valent Pneumococcal Vaccine players cover Merck. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of 7-Valent Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Single Dose Vial
Pre-filled Syringe
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Key Questions Addressed in this Report
What is the 10-year outlook for the global 7-Valent Pneumococcal Vaccine market?
What factors are driving 7-Valent Pneumococcal Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 7-Valent Pneumococcal Vaccine market opportunities vary by end market size?
How does 7-Valent Pneumococcal Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 7-Valent Pneumococcal Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for 7-Valent Pneumococcal Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for 7-Valent Pneumococcal Vaccine by Country/Region, 2018, 2022 & 2029
2.2 7-Valent Pneumococcal Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 7-Valent Pneumococcal Vaccine Sales by Type
2.3.1 Global 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global 7-Valent Pneumococcal Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global 7-Valent Pneumococcal Vaccine Sale Price by Type (2018-2023)
2.4 7-Valent Pneumococcal Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 7-Valent Pneumococcal Vaccine Sales by Application
2.5.1 Global 7-Valent Pneumococcal Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global 7-Valent Pneumococcal Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global 7-Valent Pneumococcal Vaccine Sale Price by Application (2018-2023)
3 Global 7-Valent Pneumococcal Vaccine by Company
3.1 Global 7-Valent Pneumococcal Vaccine Breakdown Data by Company
3.1.1 Global 7-Valent Pneumococcal Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global 7-Valent Pneumococcal Vaccine Sales Market Share by Company (2018-2023)
3.2 Global 7-Valent Pneumococcal Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global 7-Valent Pneumococcal Vaccine Revenue by Company (2018-2023)
3.2.2 Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global 7-Valent Pneumococcal Vaccine Sale Price by Company
3.4 Key Manufacturers 7-Valent Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 7-Valent Pneumococcal Vaccine Product Location Distribution
3.4.2 Players 7-Valent Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for 7-Valent Pneumococcal Vaccine by Geographic Region
4.1 World Historic 7-Valent Pneumococcal Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global 7-Valent Pneumococcal Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global 7-Valent Pneumococcal Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic 7-Valent Pneumococcal Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global 7-Valent Pneumococcal Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global 7-Valent Pneumococcal Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas 7-Valent Pneumococcal Vaccine Sales Growth
4.4 APAC 7-Valent Pneumococcal Vaccine Sales Growth
4.5 Europe 7-Valent Pneumococcal Vaccine Sales Growth
4.6 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Growth
5 Americas
5.1 Americas 7-Valent Pneumococcal Vaccine Sales by Country
5.1.1 Americas 7-Valent Pneumococcal Vaccine Sales by Country (2018-2023)
5.1.2 Americas 7-Valent Pneumococcal Vaccine Revenue by Country (2018-2023)
5.2 Americas 7-Valent Pneumococcal Vaccine Sales by Type
5.3 Americas 7-Valent Pneumococcal Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 7-Valent Pneumococcal Vaccine Sales by Region
6.1.1 APAC 7-Valent Pneumococcal Vaccine Sales by Region (2018-2023)
6.1.2 APAC 7-Valent Pneumococcal Vaccine Revenue by Region (2018-2023)
6.2 APAC 7-Valent Pneumococcal Vaccine Sales by Type
6.3 APAC 7-Valent Pneumococcal Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 7-Valent Pneumococcal Vaccine by Country
7.1.1 Europe 7-Valent Pneumococcal Vaccine Sales by Country (2018-2023)
7.1.2 Europe 7-Valent Pneumococcal Vaccine Revenue by Country (2018-2023)
7.2 Europe 7-Valent Pneumococcal Vaccine Sales by Type
7.3 Europe 7-Valent Pneumococcal Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 7-Valent Pneumococcal Vaccine by Country
8.1.1 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Type
8.3 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 7-Valent Pneumococcal Vaccine
10.3 Manufacturing Process Analysis of 7-Valent Pneumococcal Vaccine
10.4 Industry Chain Structure of 7-Valent Pneumococcal Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 7-Valent Pneumococcal Vaccine Distributors
11.3 7-Valent Pneumococcal Vaccine Customer
12 World Forecast Review for 7-Valent Pneumococcal Vaccine by Geographic Region
12.1 Global 7-Valent Pneumococcal Vaccine Market Size Forecast by Region
12.1.1 Global 7-Valent Pneumococcal Vaccine Forecast by Region (2024-2029)
12.1.2 Global 7-Valent Pneumococcal Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 7-Valent Pneumococcal Vaccine Forecast by Type
12.7 Global 7-Valent Pneumococcal Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck 7-Valent Pneumococcal Vaccine Product Portfolios and Specifications
13.1.3 Merck 7-Valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
14 Research Findings and Conclusion
*If Applicable.